Samsung Biologics to raise about KRW 3T via rights issue
Samsung Biologics plans to raise about KRW 3T through a rights issue.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Samsung Biologics plans to raise about KRW 3T through a rights issue.